The Proteus Digital Health biosensor pill has ramifications that transcend earnings for the company or a few patents. It is the perfect convergence of sensors, remote monitoring and mobile health and it is clinical enough to be on doctors' radar.
Novartis AG plans to seek regulatory approval within 18 months for a pioneering tablet containing an embedded microchip that sends information to your doctor about whether you took your medication and how it's working, according to Reuters.
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.